Jennifer Buell | President and Chief Executive Officer |
Christine Klaskin | Principal Financial and Accounting Officer |
Emily Bodnar | H.C. Wainwright |
Jack Allen | Baird |
Good morning, and welcome to MiNK Therapeutics' Third Quarter 2022 Conference Call and Webcast. All participants will be in a listen-only mode until the question-and-answer session. Please note, this event is being recorded. If anyone has any objections, you may disconnect at this time. Today's call is being webcasted and will be available on our website for replay.